Hunan Aikang Pharmaceutical Group

Hunan Aikang Pharmaceutical Group is a large-scale Chinese pharmaceutical enterprise focused on the research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished dosages. The company is particularly recognized for its 'Qianlie Kang' brand, a traditional Chinese medicine (TCM) product derived from Pollen Typhae used for prostate health management. Its pharmaceutical portfolio also includes a broad range of small molecule generics targeting cardiovascular, anti-infective, and digestive therapeutic areas. Hunan Aikang operates several integrated production bases and research institutes, positioning itself as a key supplier in both the domestic Chinese market and the global API supply chain.